Ferran Nadeu-rekin lankidetzan egindako argitalpenak (23)

2023

  1. MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution

    Blood Cancer Journal

  2. Correction: ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution (Blood Cancer Journal, (2022), 12, 6, (90), 10.1038/s41408-022-00686-6)

    Blood Cancer Journal

  3. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

    Nature Medicine, Vol. 28, Núm. 8, pp. 1662-1671

  4. Molecular map of chronic lymphocytic leukemia and its impact on outcome

    Nature Genetics, Vol. 54, Núm. 11, pp. 1664-1674

  5. PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

    Blood, Vol. 137, Núm. 21, pp. 2935-2946

  2. mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies

    Communications Biology, Vol. 4, Núm. 1

2020

  1. Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma

    Haematologica

  2. Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia

    Annual Review of Pathology: Mechanisms of Disease, Vol. 15, pp. 149-177

  3. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

    Blood, Vol. 136, Núm. 12, pp. 1419-1432

  4. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

    Nature Communications, Vol. 11, Núm. 1

  5. Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis

    Leukemia, Vol. 34, Núm. 7, pp. 1929-1933

  6. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

    Nature Cancer, Vol. 1, Núm. 11, pp. 1066-1081

  7. Timing the initiation of multiple myeloma

    Nature Communications, Vol. 11, Núm. 1

2019

  1. A practical guide for mutational signature analysis in hematological malignancies

    Nature Communications, Vol. 10, Núm. 1

  2. Author Correction: A practical guide for mutational signature analysis in hematological malignancies (Nature Communications, (2019), 10, 1, (2969), 10.1038/s41467-019-11037-8)

    Nature Communications

  3. Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

    Haematologica, Vol. 104, Núm. 3, pp. 576-586

  4. The U1 spliceosomal RNA is recurrently mutated in multiple cancers

    Nature, Vol. 574, Núm. 7780, pp. 712-716

2018

  1. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Leukemia, Vol. 32, Núm. 3, pp. 645-653